"Stomatitis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
INFLAMMATION of the soft tissues of the MOUTH, such as MUCOSA; PALATE; GINGIVA; and LIP.
Descriptor ID |
D013280
|
MeSH Number(s) |
C07.465.864
|
Concept/Terms |
Oral Mucositis- Oral Mucositis
- Mucositides, Oral
- Oral Mucositides
- Oromucositis
- Oromucositides
- Mucositis, Oral
|
Below are MeSH descriptors whose meaning is more general than "Stomatitis".
Below are MeSH descriptors whose meaning is more specific than "Stomatitis".
This graph shows the total number of publications written about "Stomatitis" by people in this website by year, and whether "Stomatitis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2013 | 0 | 1 | 1 |
2017 | 5 | 1 | 6 |
2018 | 2 | 2 | 4 |
2020 | 2 | 2 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Stomatitis" by people in Profiles.
-
Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization. N Engl J Med. 2021 06 17; 384(24):2354-2356.
-
The impact of the COVID-19 outbreak on supportive care for oral mucositis: current concepts and practice. Support Care Cancer. 2021 May; 29(5):2255-2258.
-
The manifestation of oral mucositis in COVID-19 patients: A case-series. Dermatol Ther. 2020 11; 33(6):e14479.
-
Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children. Clin Immunol. 2020 12; 221:108613.
-
Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content. Med Hypotheses. 2020 Oct; 143:110150.
-
Oral vesicles and acral erythema: report of a cutaneous manifestation of COVID-19. Int J Dermatol. 2020 Sep; 59(9):1153-1154.
-
Impact of pandemic COVID-19 outbreak on oral mucositis preventive and treatment protocols: new perspectives for extraoral photobiomodulation therapy. Support Care Cancer. 2020 Oct; 28(10):4545-4548.
-
Breakthrough cancer pain tailored treatment: which factors influence the medication choice? An observational, prospective and cross-sectional study in patients with terminal cancer. Postgrad Med J. 2018 Oct; 94(1116):566-570.
-
Efficacy and safety of everolimus in hormone receptor positive breast cancer in a developing country: Real-life single institutional experience. J Cancer Res Ther. 2018 Jul-Sep; 14(5):1112-1116.
-
Stomatitis and VEGFR-Tyrosine Kinase Inhibitors (VR-TKIs): A Review of Current Literature in 4369 Patients. Biomed Res Int. 2018; 2018:5035217.